 | Up a level |
Benito-Villalvilla, Cristina; de la Rocha-Muñoz, Andrés; López-Abente, Jacobo; Eggel, Alexander; Bottoli, Iván; Severin, Thomas; Woisetschläger, Maximilian; Palomares, Oscar (2023). Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation. Allergy, 78(4), pp. 1060-1072. Wiley 10.1111/all.15567
Jensen-Jarolim, Erika; Bachmann, Martin F.; Bonini, Sergio; Jacobsen, Lars; Jutel, Marek; Klimek, Ludger; Mahler, Vera; Mösges, Ralph; Moingeon, Philippe; O Hehir, Robyn E; Palomares, Oscar; Pfaar, Oliver; Renz, Harald; Rhyner, Claudio; Roth-Walter, Franziska; Rudenko, Michael; Savolainen, Johannes; Schmidt-Weber, Carsten B; Traidl-Hoffmann, Claudia and Kündig, Thomas (2020). State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy, 75(4), pp. 746-760. Wiley 10.1111/all.14134
